166 related articles for article (PubMed ID: 10775994)
21. The influence of fetal position on nuchal translucency thickness.
de Graaf IM; Müller MA; van Zuylen-Vié AA; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 2000 Jun; 15(6):520-2. PubMed ID: 11005121
[TBL] [Abstract][Full Text] [Related]
22. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
23. Fetal nuchal translucency: a prenatal screening tool.
Beamer LC
J Obstet Gynecol Neonatal Nurs; 2001; 30(4):376-85. PubMed ID: 11461021
[TBL] [Abstract][Full Text] [Related]
24. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
Hafner E; Schuchter K; Philipp K
Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
[TBL] [Abstract][Full Text] [Related]
25. Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation.
Salomon LJ; Bernard JP; Taupin P; Benard C; Ville Y
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):636-7. PubMed ID: 11844204
[TBL] [Abstract][Full Text] [Related]
26. Implementation of nuchal translucency image-scoring method during ongoing audit.
Herman A; Dreazen E; Maymon R; Tovbin Y; Bukovsky I; Weinraub Z
Ultrasound Obstet Gynecol; 1999 Dec; 14(6):388-92. PubMed ID: 10658276
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and outcome of increased nuchal translucency in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria: A cohort study.
Sulaiman B; Shehu CE; Panti AA; Saidu SA; Onankpa B; Ekele BA
Niger J Clin Pract; 2020 Jun; 23(6):864-869. PubMed ID: 32525124
[TBL] [Abstract][Full Text] [Related]
28. Nuchal translucency.
Blakemore KJ
Ultrasound Obstet Gynecol; 1998 Jun; 11(6):388-90. PubMed ID: 9674083
[No Abstract] [Full Text] [Related]
29. First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling.
Brambati B; Cislaghi C; Tului L; Alberti E; Amidani M; Colombo U; Zuliani G
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):9-14. PubMed ID: 7850598
[TBL] [Abstract][Full Text] [Related]
30. [Screening for trisomy 21 by measuring nuchal translucency during the first trimester of pregnancy].
Charasson T; Ko-Kivok-Yun P; Martin F; Sarramon MF
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(7):671-8. PubMed ID: 9471429
[TBL] [Abstract][Full Text] [Related]
31. Assessment of first-trimester nuchal translucency by daily reference intervals.
Yagel S; Anteby EY; Rosen L; Yaffe E; Rabinowitz R; Tadmor O
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):262-5. PubMed ID: 9618849
[TBL] [Abstract][Full Text] [Related]
32. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
[TBL] [Abstract][Full Text] [Related]
33. The effect of image size on nuchal translucency measurement.
Edwards A; Mulvey S; Wallace EM
Prenat Diagn; 2003 Apr; 23(4):284-6. PubMed ID: 12673630
[TBL] [Abstract][Full Text] [Related]
34. [Pregnancy outcome in fetuses with increased nuchal translucency thickness at 10-14 weeks of pregnancy].
Maymon R; Dreazen E; Tovbin Y; Weinraub Z; Herman A
Harefuah; 1999 Jun; 136(11):851-5, 916, 915. PubMed ID: 10955127
[TBL] [Abstract][Full Text] [Related]
35. Nuchal translucency audit: a novel image-scoring method.
Herman A; Maymon R; Dreazen E; Caspi E; Bukovsky I; Weinraub Z
Ultrasound Obstet Gynecol; 1998 Dec; 12(6):398-403. PubMed ID: 9918088
[TBL] [Abstract][Full Text] [Related]
36. The role of fetal nuchal translucency in prenatal screening.
Snijders R; Smith E
Curr Opin Obstet Gynecol; 2002 Dec; 14(6):577-85. PubMed ID: 12441696
[TBL] [Abstract][Full Text] [Related]
37. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
38. [Down syndrome screening by ultrasound].
Rozenberg P
Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
[TBL] [Abstract][Full Text] [Related]
39. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
Thilaganathan B; Slack A; Wathen NC
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
[TBL] [Abstract][Full Text] [Related]
40. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester.
Whitlow BJ; Economides DL
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):258-61. PubMed ID: 9618848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
